Marvell and Micron: Can These AI Chip Stocks Still Be Chased after Triple-Digit Surges?

Technology

Triple-Digit Gains Haven’t Killed This Biotech’s Upside. Here’s What Comes Next

Life Science

Palantir Is Down 38% and Just Got Upgraded. Here’s Why Investors Should Remain Cautious

Technology

Tesla Keeps Promising, This Self-Driving Stock Is Already Delivering

Technology

Micron’s 20% Retreat: Why Wall Street Is Still Betting on a 75% Rally

Technology

AXSM vs. ALNY: Which Biotech Has the DNA of a Millionaire-Maker?

Life Science

Amazon Has Doubled Since Its Split. Why Is It Cheaper Than in 2022?

Technology

Electric Vehicles Can’t Save Tesla: Shares Tumble 7.5% After Blowout Deliveries

Technology

Almonty’s Sangdong Tungsten Mine Begins Commercial Production: Why It Matters

Mining

SanDisk’s 858% Surge Is No Fluke—Three Days of Turmoil Only Strengthened the Case

Technology

Streaming Giant on Sale: Why Netflix’s 44% Sell-Off May Be Overdone

Consumer Goods

Small-Cap U.S. Stocks Trounce S&P 500 in First Half; Seven Top Small-Cap ETFs to Watch

Financial Service, Life Science, Technology

RXRX vs. SMMT: Two Biotechs, Two Very Different Bets

Life Science

Buffett Indicator Hits All-Time High—What Does History Tell Investors?

Technology

Strategy Ends Six-Year ‘Never Sell’ Bitcoin Streak With $1.25B Plan As Crypto Winter Bites

Cryptocurrency